StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) stock

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$0.84−0.05 (-5.73%)

Close on Nov 20, 2026Market cap $91.95KP/E –Yield –

XORTX Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for XORTX Therapeutics

XORTX Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More XORTX Therapeutics figures

See a number that looks wrong?